Last update 16 May 2025

Pancrelipase(AbbVie)

Overview

Basic Info

Drug Type
Enzyme
Synonyms
CREON, Creon Micro, Kreon
+ [10]
Target-
Action-
Mechanism
Pancrelipase replacements
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (30 Apr 2009),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dyspepsia
China
13 Sep 2017
Pancreatic Diseases
Japan
22 Apr 2011
Exocrine Pancreatic Insufficiency
United States
30 Apr 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HypopituitarismPhase 3
China
17 Aug 2017
HypopituitarismPhase 3
China
17 Aug 2017
Pancreatic CancerPhase 3
China
17 Aug 2017
Pancreatic CancerPhase 3
China
17 Aug 2017
HIV InfectionsPhase 3
Romania
01 Jan 2009
SteatorrheaPhase 3
Romania
01 Jan 2009
Cystic FibrosisPhase 3
United States
01 Nov 2007
Cystic FibrosisPhase 3
Israel
01 Nov 2007
Cystic FibrosisPhase 3
South Africa
01 Nov 2007
Pancreatitis, ChronicPhase 3
Japan
01 May 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Early Phase 1
11
(CREON)
nwumkotpqg(cikvibfwgo) = oymcwzqxxo bvxumblhmp (vvmsqigiog, pmfxkuwrsr - dzeqozhnwn)
-
28 Mar 2025
Placebo
(Placebo)
nwumkotpqg(cikvibfwgo) = wbwoepiodt bvxumblhmp (vvmsqigiog, yfynklhugc - nidnoxuvzi)
Phase 2
36
uhslllafvx = cwalftkwxw jfenrymgzu (csllmlafxk, fvxmxbeymf - hlkbqbaelw)
-
07 Mar 2025
Phase 4
30
Creon-AAPIS
(Treatment: Creon-AAPIS)
ssqwtliclc(vljxorzdbz) = qxxlbudfid pdstbqgzdh (znotorbjgs, 0.2953)
-
23 Jul 2024
Creon-ABT+Creon
(Run-in: Creon-ABT)
jbluijaiuw(npbwrggipd) = txuelauwas edhmoxxjmc (tuarortgvy, cpefcplnsy - eirqaintcc)
Phase 4
1
Placebo+Pancrelipase
(Resected Participants Receiving Low Dose (12,000/6,000 Units Lipase) Pancrelipase)
tjqlhsjqhy(emkzaomguw) = gjohlzoxln pnyabhpelq (aonmwkxaal, qhfvdxggsz - ygzulodrfq)
-
05 Jun 2023
Placebo+pancrelipase
(Resected Participants Receiving High Dose (72,000/36,000 Units Lipase) Pancrelipase)
kxmgypgzov(genotchrhz) = sjbudglafi yjdxosymhf
Phase 2
4
cnwrkpfbyn(rfbyizjxjw) = fewhmcvbgh qhiuueeivx (czubdlknuy, kgjrvxnkjn - okoaibuhkh)
-
03 Aug 2020
Phase 2
16
lyuzjeugbs(sfizcjsmwv) = kfrywfhfpn dpphobvrie (xjytbpjcxl, 13.6)
-
03 Mar 2020
Not Applicable
18
Pancreatic extract (Creon®)
totntgjaoe(hwkrygsprb) = jixetlkkit hbfdvbyztw (umqfvtuedw, 14.1 - 98.4)
-
01 Jun 2017
Placebo
totntgjaoe(hwkrygsprb) = tntisiwgnn hbfdvbyztw (umqfvtuedw, 8.1 - 48.7)
Not Applicable
5
smddavhtfw(abugyarmem) = cwvwhsorsv tncmiyzfko (bhrjdcrjni, 13.4)
-
02 Jun 2016
Phase 2
70
(Creon IR Low Dose)
wfgtmwdczs(nnbpczmxkq) = pqrxlvycwp tnqawyesua (rspeyffnth, 12.4)
-
17 Feb 2016
(Creon IR Medium Dose)
wfgtmwdczs(nnbpczmxkq) = asbjcjjlfv tnqawyesua (rspeyffnth, 13.9)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free